These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19010673)

  • 1. The discovery of highly potent CGRP receptor antagonists.
    Stump CA; Bell IM; Bednar RA; Bruno JG; Fay JF; Gallicchio SN; Johnston VK; Moore EL; Mosser SD; Quigley AG; Salvatore CA; Theberge CR; Blair Zartman C; Zhang XF; Kane SA; Graham SL; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2009 Jan; 19(1):214-7. PubMed ID: 19010673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent benzimidazolone-based CGRP receptor antagonists.
    Theberge CR; Bednar RA; Bell IM; Corcoran HA; Fay JF; Hershey JC; Johnston VK; Kane SA; Mosser S; Salvatore CA; Williams TM; Zartman CB; Zhang XF; Graham SL; Vacca JP
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6122-5. PubMed ID: 18947992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonists.
    Bell IM; Bednar RA; Fay JF; Gallicchio SN; Hochman JH; McMasters DR; Miller-Stein C; Moore EL; Mosser SD; Pudvah NT; Quigley AG; Salvatore CA; Stump CA; Theberge CR; Wong BK; Zartman CB; Zhang XF; Kane SA; Graham SL; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6165-9. PubMed ID: 17027263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in rats.
    Bell IM; Stump CA; Gallicchio SN; Staas DD; Zartman CB; Moore EL; Sain N; Urban M; Bruno JG; Calamari A; Kemmerer AL; Mosser SD; Fandozzi C; White RB; Zrada MM; Selnick HG; Graham SL; Vacca JP; Kane SA; Salvatore CA
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3941-5. PubMed ID: 22607672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of potent, orally bioavailable tricyclic CGRP receptor antagonists.
    Bell IM; Bednar RA; Corcoran HA; Fay JF; Gallicchio SN; Johnston VK; Hershey JC; Miller-Stein CM; Moore EL; Mosser SD; Roller SA; Salvatore CA; Theberge CR; Wong BK; Blair Zartman C; Kane SA; Williams TM; Graham SL; Vacca JP
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4740-2. PubMed ID: 19577468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potent, highly constrained CGRP receptor antagonists.
    Stump CA; Bell IM; Bednar RA; Fay JF; Gallicchio SN; Hershey JC; Jelley R; Kreatsoulas C; Moore EL; Mosser SD; Quigley AG; Roller SA; Salvatore CA; Sharik SS; Theberge CR; Zartman CB; Kane SA; Graham SL; Selnick HG; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2572-6. PubMed ID: 20299218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibility.
    Wood MR; Schirripa KM; Kim JJ; Quigley AG; Stump CA; Bell IM; Bednar RA; Fay JF; Bruno JG; Moore EL; Mosser SD; Roller S; Salvatore CA; Kane SA; Vacca JP; Selnick HG
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5787-90. PubMed ID: 19703767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist.
    Salvatore CA; Moore EL; Calamari A; Cook JJ; Michener MS; O'Malley S; Miller PJ; Sur C; Williams DL; Zeng Z; Danziger A; Lynch JJ; Regan CP; Fay JF; Tang YS; Li CC; Pudvah NT; White RB; Bell IM; Gallicchio SN; Graham SL; Selnick HG; Vacca JP; Kane SA
    J Pharmacol Exp Ther; 2010 Apr; 333(1):152-60. PubMed ID: 20065019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally bioavailable imidazoazepanes as calcitonin gene-related peptide (CGRP) receptor antagonists: discovery of MK-2918.
    Paone DV; Nguyen DN; Shaw AW; Burgey CS; Potteiger CM; Deng JZ; Mosser SD; Salvatore CA; Yu S; Roller S; Kane SA; Selnick HG; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2011 May; 21(9):2683-6. PubMed ID: 21251825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of potent antagonists containing rigid spirocyclic privileged structures for the CGRP receptor.
    Chaturvedula PV; Pin S; Tholady G; Conway CM; Macor JE; Dubowchik GM
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4719-22. PubMed ID: 22732695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of azepanone calcitonin gene-related peptide (CGRP) receptor antagonists: development of novel spiropiperidines.
    Burgey CS; Potteiger CM; Deng JZ; Mosser SD; Salvatore CA; Yu S; Roller S; Kane SA; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6368-72. PubMed ID: 19818613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
    Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974).
    Paone DV; Shaw AW; Nguyen DN; Burgey CS; Deng JZ; Kane SA; Koblan KS; Salvatore CA; Mosser SD; Johnston VK; Wong BK; Miller-Stein CM; Hershey JC; Graham SL; Vacca JP; Williams TM
    J Med Chem; 2007 Nov; 50(23):5564-7. PubMed ID: 17929795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead.
    Williams TM; Stump CA; Nguyen DN; Quigley AG; Bell IM; Gallicchio SN; Zartman CB; Wan BL; Penna KD; Kunapuli P; Kane SA; Koblan KS; Mosser SD; Rutledge RZ; Salvatore C; Fay JF; Vacca JP; Graham SL
    Bioorg Med Chem Lett; 2006 May; 16(10):2595-8. PubMed ID: 16527483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin gene-related peptide (CGRP) receptor antagonists: investigations of a pyridinone template.
    Nguyen DN; Paone DV; Shaw AW; Burgey CS; Mosser SD; Johnston V; Salvatore CA; Leonard YM; Miller-Stein CM; Kane SA; Koblan KS; Vacca JP; Graham SL; Williams TM
    Bioorg Med Chem Lett; 2008 Jan; 18(2):755-8. PubMed ID: 18039571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonist.
    Yang H; Lin XF; Padilla F; Gabriel SD; Heilek G; Ji C; Sankuratri S; deRosier A; Berry P; Rotstein DM
    Bioorg Med Chem Lett; 2009 Jan; 19(1):209-13. PubMed ID: 19014885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of imidazoles as potent calcitonin gene-related peptide (CGRP) antagonists.
    Tora G; Degnan AP; Conway CM; Kostich WA; Davis CD; Pin SS; Schartman R; Xu C; Widmann KA; Macor JE; Dubowchik GM
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5684-8. PubMed ID: 23993336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 2.
    Han X; Civiello RL; Conway CM; Cook DA; Davis CD; Degnan AP; Jiang XJ; Macci R; Mathias NR; Moench P; Pin SS; Schartman R; Signor LJ; Thalody G; Tora G; Whiterock V; Xu C; Macor JE; Dubowchik GM
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1870-3. PubMed ID: 23402880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Drug Discovery of
    Bucknell SJ; Ator MA; Brown AJH; Brown J; Cansfield AD; Cansfield JE; Christopher JA; Congreve M; Cseke G; Deflorian F; Jones CR; Mason JS; O'Brien MA; Ott GR; Pickworth M; Southall SM
    J Med Chem; 2020 Jul; 63(14):7906-7920. PubMed ID: 32558564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent oxadiazole CGRP receptor antagonists for the potential treatment of migraine.
    Nichols PL; Brand J; Briggs M; D'Angeli M; Farge J; Garland SL; Goldsmith P; Hutchings R; Kilford I; Li HY; MacPherson D; Nimmo F; Sanderson FD; Sehmi S; Shuker N; Skidmore J; Stott M; Sweeting J; Tajuddin H; Takle AK; Trani G; Wall ID; Ward R; Wilson DM; Witty D
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1368-72. PubMed ID: 20097071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.